Exploring how language affects fertility treatment progress

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This study evaluates the impact of language concordance on the progression of fertility treatments for Spanish-speaking patients. It compares the experiences of patients who communicate with a Spanish-speaking provider versus those who use an interpreter. Participants will complete surveys in their preferred language to assess satisfaction and communication effectiveness. The study aims to identify whether language barriers delay testing and treatment initiation in fertility care.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* Must be greater than 18 years old
* Preferred language must be Spanish speaking
* Must be seeking fertility treatment

Exclusion Criteria:

* Preferred language English
* Not currently seeking fertility care
* Less than 18 years old

Where it's running

• Washington University in St Louis
  St Louis, Missouri, United States Recruiting

Study contacts

• Study coordinator: Aileen Portugal, MD
• Email: aileenp@wustl.edu
• Phone: 619-993-4298

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Environmental and lifestyle factors linked to ART success in infertility patients

  This study follows 5,000 infertile men and women to see how environmental exposures and lifestyle relate to the success of assisted reproductive technology.

  Recruiting The Third Xiangya Hospital of Central South University · Changsha, Hunan · NCT07641387

• Higher or lower starting FSH dose for good-prognosis IVF with PPOS

  This trial tests whether starting IVF stimulation with 225 IU or 300 IU of FSH improves oocyte and embryo outcomes in good-prognosis women using PPOS.

  Recruiting Vietnam Military Medical University · Ho Chi Minh City, Ho Chi Minh City · NCT07772375

• Integrative care guided by biological aging markers for unexplained female infertility

  This trial tests whether measuring telomeres and other biological aging markers can guide a personalized integrative treatment to help women aged 25–42 with persistent unexplained infertility improve their chances of pregnancy.

  Recruiting BEYOND GENOMiX SA, AG, Ltd · Neuchâtel · NCT07404969

• Standardizing embryo transfer steps for frozen embryo transfers

  This trial tests whether using specialized transfer devices to keep embryos warm and deliver them with precise, controlled motion can increase pregnancy success for people having frozen embryo transfer after IVF/ICSI.

  Recruiting Przychodnia Lekarska nOvum Katarzyna Kozioł, Piotr Lewandowski sp.k. · Warsaw · NCT07396181

• How infertility and fertility treatments affect women's sexual function and behavior

  This project tries to see if infertility and fertility treatments like IVF change sexual desire, satisfaction, or sexual activity in women under 45 seeking fertility care.

  Recruiting McGill University Health Centre/Research Institute of the McGill University Health Centre · Montreal, Quebec · NCT07376109

• Growth hormone versus DHEA to boost follicle response in IVF for poor ovarian responders

  This trial will test whether adding growth hormone or DHEA helps women with poor ovarian reserve produce more and larger follicles during ICSI.

  Recruiting Phase 2/3 Beni-Suef University · Banī Suwayf, Beni Suweif Governorate · NCT07323329

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.